会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 81. 发明申请
    • Semiconductor memory device
    • 半导体存储器件
    • US20060113581A1
    • 2006-06-01
    • US11289441
    • 2005-11-30
    • Takashi MikiHiroshige Hirano
    • Takashi MikiHiroshige Hirano
    • H01L29/94
    • H01L27/11502H01L23/564H01L27/11507H01L2924/0002H01L2924/00
    • A semiconductor memory device having a memory cell array in which plural memory transistors and plural memory call capacitors, which are components of memory cells, are arranged, comprises a first wiring layer formed on the memory cell array, and a second wiring layer formed above the first wiring layer, wherein a wiring density of the first wiring layer on the memory cell array is higher than a wiring density of the second wiring layer on the memory cell array. Therefore, a hydrogen barrier property for the capacitors is improved, and an adverse effect due to stress applied to the capacitors is reduced, thereby suppressing deterioration of capacitor characteristics.
    • 一种具有存储单元阵列的半导体存储器件,其中布置有作为存储单元的组件的多个存储晶体管和多个存储器调用电容器,包括形成在存储单元阵列上的第一布线层和形成在存储单元阵列上方的第二布线层 第一布线层,其中存储单元阵列上的第一布线层的布线密度高于存储单元阵列上的第二布线层的布线密度。 因此,电容器的氢阻挡性提高,并且由于施加到电容器的应力引起的不利影响降低,从而抑制电容器特性的劣化。
    • 85. 发明授权
    • 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
    • 4,1-苯并氧氮杂,它们的类似物,以及它们作为生长抑素激动剂的用途
    • US06352982B1
    • 2002-03-05
    • US09403066
    • 1999-10-14
    • Hiroshi MabuchiNobuhiro SuzukiTakashi Miki
    • Hiroshi MabuchiNobuhiro SuzukiTakashi Miki
    • C07D26714
    • C07D231/12C07D233/56C07D243/24C07D249/08C07D267/14C07D281/10C07D413/04C07D413/06C07D413/12C07D417/06C07D417/12
    • The present invention provides a compound of the formula: wherein ring A is an optionally substituted aromatic hydrocarbon ring or aromatic heterocyclic ring; ring B is an optionally substituted aromatic hydrocarbon ring or aromatic heterocyclic ring; Z is an optionally substituted cyclic group or linear hydrocarbon group; R1 is a hydrogen atom, an optionally substituted hydrocarbon group or heterocyclic ring; R2 is an optionally substituted amino group; D is a bond or an optionally substituted divalent hydrocarbon group; E is a bond, —CON(Ra)—, —N(Ra)CO—, —N(Rb)CON(Rc)—, —N(Rd)COO—, —N(Re)SO2—, —COO—, —N(Rf)—, —O—, —S— —SO—, —SO2—, (in which Ra, Rb, Rc, Rd, Re and Rf are respectively a hydrogen atom or an optionally substituted hydrocarbon group); G is a bond or an optionally divalent substituted hydrocarbon group; L is a divalent group; ring B may form an optionally substituted non-aromatic condensed nitrogen-containing heterocyclic ring by combining with R2; X is two hydrogen atoms, an oxygen atom or a sulfur atom; is a single bond or a double bond, and Y is a nitrogen atom when is a double bond, or an oxygen atom, —N(R4)— (in which R4 is a hydrogen atom, an optionally substituted hydrocarbon group or an acyl group) or S(O)n (in which n is 0, 1 or 2) when is a single bond, or a salt thereof, which have somatostatin receptor agonistic action.
    • 本发明提供下式的化合物:其中环A是任选取代的芳族烃环或芳族杂环; 环B是任选取代的芳族烃环或芳族杂环; Z是任选取代的环状基团或直链烃基; R1是氢原子,任选取代的烃基或杂环; R2是任选取代的氨基; D是键或任选取代的二价烃基; E是键,-CON(Ra) - , - N(Ra)CO-,-N(Rb)CON(Rc) - , - N(Rd)COO-,-N(Re)SO2-,-COO- ,-N(R f) - , - O - , - S - -SO - , - SO 2 - (其中Ra,Rb,Rc,Rd,Re和Rf分别为氢原子或任选取代的烃基)。 G是键或任选的二价取代的烃基; L是二价基团;环B可以与R2结合形成任选取代的非芳族稠合含氮杂环; X是两个氢原子,一个氧原子或一个硫原子; 是单键或双键,当是双键或氧原子-N(R4) - (其中R4是氢原子,任选取代的烃基或酰基) )或S(O)n(其中n为0,1或2),当是单键时,或 其盐,其具有生长抑素受体激动作用。